title: Cost-control mechanisms in Canadian private drug plans.
abstract: Approximately 68% of Canadians receive prescription drug coverage through an employer-sponsored private plan. However, we have very limited data on the structure of these plans. This study aims to identify and describe the use of cost-control mechanisms in private drug plans in Canada and describe what private coverage looks like for the average Canadian. Using 2010 data from over 113,000 different private drug plans, provided by Applied Management Consultants, we determined the overall use of key cost-control measures, and the cost-control tools that appear to be gaining currency compared to a report on benefits coverage in 1998. We found that the use of common cost-control measures is relatively low among Canadian private benefits programs. Co-insurance is much more common in private coverage plans than co-payments. Deductibles are uncommon in Canada and, when in place, are very small. The use of annual and lifetime maximums is increasing. Canadian private benefits programs use few cost-control measures to respond to increasing costs, particularly in comparison to their public counterparts. These results suggest there are ample opportunities for greater efficiency in private sector drug coverage plans.
authors: Research Assistant, Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC.
authors: Jillian
authors: J
authors: Kratzer
authors: Kimberlyn
authors: K
authors: McGrail
authors: Erin
authors: E
authors: Strumpf
authors: Michael R
authors: MR
authors: Law
mesh_terms: D002170:Canada; D003361:Cost Allocation; D003363:Cost Control / Q000379:methods*; D016527:Drug Costs / Q000706:statistics & numerical data; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D055553:Prescription Drugs / Q000191:economics
chemical_list: D016568:Drugs, Generic; D055553:Prescription Drugs
references: Health Aff (Millwood). 2003 Jul-Aug;22(4):220-9
references: 12889771
references: Health Policy. 2012 Jan;104(1):19-26
references: 21978939
references: JAMA. 2001 Jan 24-31;285(4):421-9
references: 11242426
references: Health Aff (Millwood). 2006 Sep-Oct;25(5):1319-31
references: 16966729
references: JAMA. 2007 Jul 4;298(1):61-9
references: 17609491
references: Clin Ther. 2011 May;33(5):598-607
references: 21665044
references: Med Care. 2010 Feb;48(2):87-94
references: 20068489
references: N Engl J Med. 2003 Aug 21;349(8):768-75
references: 12930930
references: CMAJ. 2009 Aug 4;181(3-4):E43-5
references: 19652155
references: Pharmacotherapy. 2005 Aug;25(8):1035-43
references: 16207093
references: Healthc Policy. 2006 Nov;2(2):e129-53
references: 19305696
references: J Health Polit Policy Law. 2010 Oct;35(5):705-42
references: 21123668